Antibiotic Labeling Revisions For Changes In Efficacy Suggested By Cmte.
Executive Summary
Older antibiotics should be reviewed for potential labeling updates regarding their efficacy against certain pathogens, members of FDA's Anti-Infective Drugs Advisory Committee said July 11